High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland

Gynecologic Oncology

Volumn 108, Issue 2, 2008, Pages 433-437

  Brozek, Izabela ^a,b   Ochman, Karolina ^a   Debniak, Jarosław ^a   Morzuch, Lucyna ^a,c   Ratajska, Magdalena ^a   Stepnowska, Magdalena ^a   Stukan, Maciej ^a   Emerich, Janusz ^a   Limon, Janusz ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Regional Oncological Center   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

BRCA1; BRCA2; Hereditary; Mutations; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; CORRELATION ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LOG RANK TEST; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLAND;

EID: 38649137993     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.09.035     Document Type: Article

References (29)

1. Pharoah P.D.P., and Ponder B.A.J. The genetics of ovarian cancer. Best Pract Res 16 (2002) 449-468
2. Statement of the American Society of Clinical Oncology (ASCO). Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 14 5 (May 1996) 1730-1736 [discussion 1737-40]
3. Moslehi R., Chu W., Karlan B., Fishman D., Risch H., Fields A., et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66 (2000) 1259-1272
4. Pal T., Permuth-Wey J., Betts J.A., Krischer J.P., Fiorica J., Arango H., et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104 (2005) 2807-2816
5. Geisler J.P., Hatterman-Zogg M.A., Rathe J.A., and Buller R.E. Frequency of BRCA1 dysfunction in ovarian cancer. J Nat Cancer Inst 94 (2002) 61-67
6. Tumors of ovary and peritoneum. In: Tavassoli F.A., and Deville P. (Eds). WHO Classification of tumours, pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon 116
7. Perkowska M., Brożek I., Wysocka B., Haraldsson K., Sandberg T., Johansson U., et al. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from North-Eastern Poland. Hum Mutat 21 (2003) 553-554
8. Wagner T., Stoppa-Lyonnet D., Fleischmann E., Muhr D., Pages S., Sandberg T., et al. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62 (1999) 369-376
9. Palomba G., Pisano M., Cossu A., Budroni M., Dedola M.F., Farris A., et al. Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening. Cancer 104 (2005) 1172-1179
10. Grzybowska E., Siemińska M., Zientek H., Kalinowska E., Michalska J., Utracka-Hutka B., et al. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. Acta Biochim Pol 49 (2002) 351-356
11. Menkiszak J., Gronwald J., Górski B., Jakubowska A., Huzarski T., Byrski T., et al. Hereditary ovarian cancer in Poland. Int J Cancer 106 (2003) 942-945
12. Berchuck A., Heron K., Carney M.E., Lancaster J.M., Fraser E.G., Vinson V.L., et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4 (1998) 2433-2437
13. Van der Looij M., Szabo C., Besznyak I., Liszka G., Csokay B., Pulay T., et al. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86 (2000) 737-740
14. Stratton J.F., Gayther S.A., Russell P., Dearden J., Gore M., Blake P., et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336 (1997) 1125-1130
15. Malander S., Ridderheim M., Masback A., Loman N., Kristoffersson U., Olsson H., et al. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40 (2004) 422-428
16. Risch H.A., McLaughlin J.R., Cole D.E., Rosen B., Bradley L., Kwan E., et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68 (2001) 700-710
17. Ben-David Y., Chetrit A., Hirsh-Yechezkel G., Friedman E., Beck B.D., Beller U., et al. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 20 (2002) 463-466
18. Hirsh-Yechezkel G., Chetrit A., Lubin F., Friedman E., Peretz T., Gershoni R., et al. Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel. Gynecol Oncol 89 (2003) 494-498
19. Tikhomirova L., Sinicka O., Smite D., Eglitis J., Hodgson S.V., and Stengrevics A. High prevalence of two BRCA1 mutations 4154delA and 5382insC in Latvia. Fam Cancer 4 (2005) 77-84
20. Gronwald J., Elsakov P., Górski B., and Lubiński J. High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat 94 (2005) 111-113
21. Grudinina N.A., Golubkov V.I., Tikhomirova O.S., Brezhneva T.V., Hanson K.P., Vasilyev V.B., et al. Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St Petersburg. Genetika 41 (2005) 405-410
22. Salazar R., Cruz-Hernandez J.J., Sanchez-Valdivieso E., Rodriguez C.A., Gomez-Bernal A., Barco E., et al. BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain. Cancer Lett 233 (2006) 172-177
23. Skasko E., Paszko Z., Niwinska A., Kwiatkowska E., Kruczek A., and Pienkowski T. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. Eur J Gynaecol Oncol 25 (2004) 470-474
24. Cass I., Baldwin R.L., Varkey T., Moslehi R., Narod S.A., and Karlan BY. Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97 (2003) 2187-2195
25. Ramus S.J., Fishman A., Pharoah P.D., Yarkoni S., Altaras M., and Ponder BA. Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations. Eur J Surg Oncol 27 (2001) 278-281
26. Sekine M., Nagata H., Tsuji S., Hirai Y., Fujimoto S., Hatae M., et al. Mutation analysis of BRCA1 and BRCA2 clinopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7 (2001) 3144-3150
27. Aida H., Takakuwa K., Nagata H., Tsuneki I., Takano M., Tsuji S., et al. Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin Cancer Res 4 (1998) 235-240
28. Johannsson O.T., Ranstam J., Borg A., and Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 16 (1998) 397-404
29. Pharoah P.D.P., Easton D.F., Stockton D.L., Gayther S., and Ponder BA. Survival in familial, BRCA1-associated and BRCA2-associated epithelial ovarian cancer. Cancer Res 59 (1999) 868-871